Category: News

DRI Healthcare Trust Comments on Proposed Acquisition of KalVista Therapeutics, Inc.

TORONTO, April 29, 2026 /CNW/ DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) today noted the announcement by KalVista Therapeutics, Inc. (“KalVista”), that it has entered into a definitive agreement to be acquired by Chiesi Group, an international research-focused biopharmaceutical group (the “Transaction”). DRI Healthcare congratulates KalVista on the announced Transaction. As previously disclosed, DRI Healthcare […]

DRI Healthcare to Host First Quarter 2026 Earnings Call and Webcast on May 15, 2026

TORONTO, April 24, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its first quarter 2026 financial results on Friday, May 15, 2026, at 8:00 a.m. ET. DRI […]

DRI Healthcare Trust Announces Closing of US$250 Million of Senior Secured Notes

TORONTO, March 25, 2026 /CNW/ DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) is pleased to announce that its subsidiary, DRI Healthcare LP (the “Issuer“), has successfully closed its previously announced private placement offering consisting of two tranches of senior secured notes (together, the “Notes“): Interest on the Notes is payable semi-annually, and the Notes rank pari […]

DRI Healthcare Trust Announces Closing of Preferred Securities Refinancing

TORONTO, March 20, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) is pleased to announce that it has successfully completed the closing of the previously announced private placement offering of convertible unsecured subordinated debentures (the “Debentures“) in the aggregate principal amount of C$108,723,000. The principal sum of the Debentures bear interest at the rate of 5.75% […]

DRI Healthcare Reports Fourth Quarter and Annual 2025 Results

TORONTO, March 3, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”) today announced its financial results for the quarter ended and year ended December 31, 2025. DRI Healthcare’s annual 2025 financial statements and Management’s Discussion & Analysis (“MD&A”) have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated. “2025 marked […]

DRI Healthcare Trust Announces Preferred Securities Refinancing

– Refinancing extends maturity profile of existing debt by up to two years – TORONTO, March 2, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (“DRI Healthcare”) is pleased to announce that it has entered into subscription agreements with EdgePoint Wealth Management Inc., and Alberta Investment Management Corporation (AIMCo), the holders of its outstanding 7.50% Series C preferred […]

DRI Healthcare Reports Third Quarter 2025 Results

Subsequent to the end of the quarter, DRI Healthcare acquired a royalty interest in the U.S. net sales of veligrotug and VRDN-003, for up to $300 million Portfolio assets generated Total Income of $48.7 million Reactivated NCIB and repurchased ~394 K units for $4.1 million TORONTO, Nov. 5, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”) today announced […]

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)

–Third synthetic royalty transaction & second pre-approval deal for DRI –– Further increases portfolio exposure to rare diseases ––  Long-dated cashflows, extend portfolio duration –– DRI Healthcare to pay US$55 million upfront; up to US$300 million total investment, subject to achievement of certain milestones– TORONTO, Oct. 20, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: […]

DRI Healthcare to Host Third Quarter 2025 Earnings Call and Webcast on November 6, 2025

TORONTO, Oct. 16, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its third quarter 2025 financial results on Thursday, November 6, 2025, at 8:00 a.m. ET. DRI Healthcare […]